A detailed history of Holocene Advisors, LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Holocene Advisors, LP holds 2,689,456 shares of KURA stock, worth $29 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,689,456
Previous 2,689,456 -0.0%
Holding current value
$29 Million
Previous $55.4 Million 5.1%
% of portfolio
0.23%
Previous 0.25%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$17.53 - $22.98 $4.42 Million - $5.79 Million
251,993 Added 10.34%
2,689,456 $55.4 Million
Q1 2023

May 15, 2023

SELL
$10.71 - $14.6 $1.08 Million - $1.48 Million
-101,142 Reduced 3.98%
2,437,463 $29.8 Million
Q4 2022

Feb 14, 2023

SELL
$11.23 - $16.9 $10.5 Million - $15.8 Million
-937,500 Reduced 26.97%
2,538,605 $31.5 Million
Q3 2022

Nov 14, 2022

BUY
$12.01 - $19.45 $2.63 Million - $4.26 Million
218,809 Added 6.72%
3,476,105 $47.5 Million
Q2 2022

Aug 15, 2022

BUY
$10.71 - $18.33 $155,166 - $265,565
14,488 Added 0.45%
3,257,296 $59.7 Million
Q1 2022

May 16, 2022

BUY
$11.78 - $16.98 $10.4 Million - $15 Million
881,977 Added 37.36%
3,242,808 $52.1 Million
Q4 2021

Feb 14, 2022

SELL
$12.22 - $19.57 $4.32 Million - $6.92 Million
-353,593 Reduced 13.03%
2,360,831 $33.1 Million
Q3 2021

Nov 15, 2021

BUY
$15.42 - $21.72 $1.95 Million - $2.75 Million
126,642 Added 4.89%
2,714,424 $50.8 Million
Q2 2021

Aug 16, 2021

BUY
$20.85 - $29.88 $7.22 Million - $10.4 Million
346,430 Added 15.46%
2,587,782 $54 Million
Q1 2021

May 17, 2021

BUY
$24.75 - $39.14 $15.4 Million - $24.3 Million
621,806 Added 38.39%
2,241,352 $63.4 Million
Q4 2020

Feb 16, 2021

BUY
$29.0 - $41.62 $10.3 Million - $14.8 Million
355,337 Added 28.11%
1,619,546 $52.9 Million
Q3 2020

Nov 16, 2020

BUY
$16.3 - $30.64 $6.05 Million - $11.4 Million
371,281 Added 41.58%
1,264,209 $38.7 Million
Q2 2020

Aug 14, 2020

BUY
$7.95 - $18.81 $7.1 Million - $16.8 Million
892,928 New
892,928 $14.6 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $722M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.